Featured news
-
Cambridge scientists uncover secret of autoimmune diseases
Trust clinicians and colleagues have shown that accumulated genetic changes could contribute to autoimmunity.
-
You Made a Difference - March 2026
Every day, across our hospital, extraordinary people go above and beyond – not for recognition, but because they care. The You Make a Difference Awards shine a light on those moments of compassion, courage and commitment that truly change lives.
-
Landmark UK study could change child brain injury treatment
ѻý are calling for a re-evaluation of guidelines used in the care of children with traumatic head injuries following the first multi-centre study of its kind in the UK.
-
Resident doctor's industrial action - 7 April - 13 April 2026
The British Medical Association (BMA) has confirmed industrial action during April 2026.
-
Cambridge Childrenѻý Hospital inaugural conference celebrates pioneering work shaping future of childrenѻý healthcare
Over a hundred delegates joined the event in Cambridge to learn more about the new hospitalѻý visionary approach for holistic care, with high profile guests including the Childrenѻý Commissioner for England Dame Rachel de Souza and broadcaster Dr Xand van Tulleken.
All news
Showing 20 results
Cambridge doctorѻý ground-breaking app gives ventilated COVID-19 patients a voice
A ground-breaking new iPad app for ICU patients - trialed at Addenbrooke's Hospital, Cambridge - is transforming the experiences and wellbeing of critically ill COVID-19 patients in the intensive care unit (ICU).
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.
Cambridge University graduates help hospital prep for pandemic
Graduates from the University of Cambridge have been combining their skills with the latest simulation software to help Addenbrookeѻý predict what resources – such as oxygen, ventilators and beds – it needs to get through the COVID crisis.
Testing suggests 3% of ѻý hospital staff may be unknowingly infected with coronavirus
Hospital staff are carrying SARS-CoV-2, the coronavirus that causes COVID-19 disease, without realising they are infected, according to a study by researchers at the University of Cambridge.
Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A collaboration with NIHR has combined whole genome sequencing with a statistical program to predict the existence of disease-causing changes in the DNA of people with primary immunodeficiency.
Two schoolboys treated at Addenbrookeѻý Hospital for cancer teach their family and friends how to cope with isolation during the coronavirus lockdown
Best buddies Oliver Doughty and Lucas Newton, both aged 12, were forced apart by cancer because their chemotherapy treatment left them prone to infection.
New ways of working help keep critically ill patients in touch with families
Staff from Addenbrookeѻý hospital are taking innovative steps to help critically ill patients stay in touch with their loved ones during the coronavirus crisis.
COVID-19 survivor says he owes his life to staff at Addenbrookeѻý
A plumber from Doddington says he owes his life to staff at Addenbrookeѻý after nearly dying from COVID-19.
Hospital launches hunt for scrubs super-heroes
ѻý ѻý Foundation Trust has launched an appeal for scrubs to help supplement existing supplies.
Research staff begin working on new COVID-19 study
Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at ѻý (CUH) to start using a new test for a research trial into COVID-19.
Adapted care for cancer patients due to COVID-19
The Cancer Research UK Cambridge Centre and six other leading European cancer centres share knowledge and experiences to define new guidelines for treating cancer patients during the COVID-19 pandemic.
Patients and visitors Finding us Services For health professionals Infection control Have your say Working for us Accessibility Contact us Cambridge researchers develop new coronavirus test for frontline ѻý workers at Addenbrookeѻý
A new test for infection with SARS-CoV2 that which inactivates the virus at the point of sampling, has been developed by a team of researchers at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID).
Cambridge engineers use industrial modelling techniques to help Addenbrookeѻý Hospital manage COVID-19 care
Modelling tools originally designed to improve the efficiency of factories are being used by Cambridge engineers to help Addenbrookeѻý Hospital manage the COVID-19 emergency.
Rapid COVID-19 diagnostic test developed by Cambridge team to be deployed in hospitals
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.
You Made a Difference team award - March 2020
A hard-working, adaptable patient-facing team are the winners of Marchѻý You Made a Difference team award
You Made a Difference - March 2020
March's You Made a Difference winners are a lead consultant neurophysiologist and a ward clerk.
Announcement of COVID-19 related death
Statement from 29 March 2020: “We can confirm that sadly, a patient in their 90s with underlying health conditions has passed away at Addenbrookeѻý Hospital. They had tested positive for COVID-19."
First CUH patient in national Covid-19 Trial
ѻý ѻý Foundation Trust has today (Friday, 27 March) enrolled its first patient into a national trial aimed at identifying treatments for Covid-19.
Team effort achieves accreditation
ѻý, as part of the Cancer Research UK Cambridge Centre, has achieved re-accreditation by the Organisation of European Cancer Institutes (OECI) as a Comprehensive Cancer Centre for a further five years.
COVID-19 research studies at CUH
In response to the COVID-19 pandemic ѻý has put in place measures to help researchers and research infrastructure deliver COVID-19 studies.